Patent Assignment
Reel/Frame 032682/0889
Assignment of Assignor's Interest
Recorded: 2014-04-16
Pages: 5
Assignors
LOIBNER, HANS
Executed: 2014-04-03
MUTSCHLECHNER, OLIVER
Executed: 2014-04-08
LADENSTEIN, RUTH
Executed: 2014-04-04
KLIER, ISABEL
Executed: 2014-04-02
Assignee
APEIRON BIOLOGICS AG
CAMPUS-VIENNA-BIOCENTER 5, VIENNA, 1030, AUSTRIA
Covered Property
(1)
Method for Treating a GD2 Positive Cancer
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
License
Sep 18, 2017
From: APEIRON BIOLOGICS AG
To: EUSA PHARMA (UK) LIMITED
Reel/Frame 043882/0511 →
Change of Name
Dec 10, 2024
From: APEIRON BIOLOGICS AG
To: APEIRON BIOLOGICS GMBH
Reel/Frame 069584/0365 →
Security Interest
Dec 23, 2024
From: APEIRON BIOLOGICS GMBH
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 069669/0908 →